SynthesisHIV medicine2025

Rapid start with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as initial treatment in people with human immunodeficiency virus-1 (HIV-1): A systematic literature review of clinical and patient-reported outcomes.

Jade Ghosn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.